Associated Papers
Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression.
Akram AM et al.
Cancer Biology & Therapy, 2017
High FLT3 expression and IL10 (G1082A) polymorphism in poor overall survival in calla acute lymphoblastic leukemia.
de Deus DM et al.
Molecular Biology Reports, 2013
Select a paper to view details